Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 600x60px

Persons > All

Please find below persons from Ireland & the United Kingdom (GB) or related to organisations from these countries.

Total search results: 3269 | Ordered by Person (ascending)
next pagenext page 1 2 3 ... 31 32 33  next pagenext page

order ascendingorder descendingPerson order ascendingorder descendingPosition order ascendingorder descendingOrganisation (Group) order ascendingorder descendingRegion
Venables, David (Synpromics 201508 CEO) Chief Executive Officer (CEO) Synpromics (Group) Scotland
Vendrell, Montserrat (Biocat 201203 CEO) Cluster Manager Biocat (BioRegion of Catalonia Private Foundation / Fundació Privada BioRegió de Catalunya) Catalonia
Venter, J. Craig n. a. VENTER Group [Craig Venter / Claire Fraser] (Group) Maryland (federal state)
Verhagen, Robert (Spectral Diagnostics 200606 VP BusDev) Business Development Manager / Strategy Manager Spectral Diagnostics Inc. (TSX: SDI) Ontario
Verhoef, Clarence (Varex Imaging 201701– CFO) Chief Financial Officer (CFO) Varex Imaging (Group) Utah (federal state)
Verjans, Benoît (Aseptic Technologies 200601 Commercial Director) n. a. GlaxoSmithKline (GSK) (Group) Belgium_o
Verleysen, Katleen (Pronota 201201– CEO before COO) Chief Executive Officer (CEO) MyCartis Flanders (Flemish region)
Vernon, N. Geoffrey n. a. Ziggus Holding Ltd. United Kingdom (state/region unspecified)
Veromaa, Timo (BioTie 1998– VP RnD promoted CEO 5/05 before Schering Oy before Collagen Corp) Chief Executive Officer (CEO) Acorda Therapeutics (Group) Länsi-Suomi
Vertes, Akos (George Washington Univ 2000– Prof before Associate Prof since 1991) Professor George Washington University Maryland (federal state)
Viant, Mark (Univ Birmingham 201303 Professor) Professor University of Birmingham West Midlands (region)
Vicary, James (NuNano 201711 Managing Director + Co-Founder) Managing Director NuNano (GB) South West England (region)
Vick, Jeffery S. (Jeff) (Généthon 201509 Director BusDev before Flamel Technologies + Silence Therapeutics) Business Development Manager / Strategy Manager French Myopathy Association (AFM) Île-de-France (region)
Vickers, Philip J. (Shire 201202 SVP RnD at Shire Human Genetic Therapies) Research & Development Manager Shire (Group) Massachusetts (federal state)
Viehbacher, Christopher A. (Chris) (Bertarelli Group 201510 Managin Partner Gurnet Point Capital before Sanofi + GSK) Managing Partner BERTARELLI Group (family of Ernesto Bertarelli) Channel Islands (Non-Commonwealth / Non-EU tax haven)
Vigodman, Erez (Teva 201608 CEO) Chief Executive Officer (CEO) Teva (Group) Israel_o
Vile, Hollie (Optimum Strategic Communicatons 201710 before Hume Brophy + M:Communications) Public Relations Manager / Investor Relations Manager Optimum Strategic Communications Greater London (region)
Villa, Laura (MolMed 201606 Investor Relations + Communication Director) Public Relations Manager / Investor Relations Manager MolMed S.p.A. (MLMD.MI) Lombardia (Lombardy)
Villette, Astrid (FTI Consulting 201612 FTI Consulting Paris) Public Relations Manager / Investor Relations Manager FTI Consulting (Group) Île-de-France (region)
VInce, Valérie (KWS Biotest 201511– Business Development Manager joined 2008 before Imperial College London) Business Development Manager / Strategy Manager Charles River (Group) South West England (region)
Viney, Jo (Biogen Idec 201311 VP Discovery Services) President/Director/Head Business Group/Unit/Division Biogen (Group) Massachusetts (federal state)
Virji, Sukaina (Suki) (Consilium 201706– joins London CSC office before 16y at Scrip/Informa) Public Relations Manager / Investor Relations Manager Consilium Strategic Communications Ltd. (CSC) Greater London (region)
Vitt, Daniel (Immunic 201701– CEO before 4SC 1997–201612 CSO + Co-Founder before Univ Würzburg) Chief Executive Officer (CEO) Immunic AG Bayern (federal state)
Voglmaier, Manfred (Definiens –200411–200810 VP BusDev Life Sciences) Business Development Manager / Strategy Manager AstraZeneca (Group) Bayern (federal state)
Vogt, Reinhard (Sartorius 201308 Executive Board Member, Marketing, Sales, Services) Sales Manager / Marketing Manager Sartorius (Group) Niedersachsen (federal state)
Volanen, Jussi (Euformatics 201711 CTO before CEO) Chief Technology/Technical Officer (CTO) Euformatics Oy Uusimaa
Volck, Birgitte (GSK 201607– Head RnD Rare Diseases before Swedish Orphan Biovitrum 2012–201606 CMO) Research & Development Manager GlaxoSmithKline (GSK) (Group) United Kingdom (state/region unspecified)
Volmer, Dietrich (Saarland Univ 201005– Professor for Analytical Chemistry before Univ Cambridge before Dalhousie Univ) Professor Saarland University (Universität des Saarlandes) Saarland (federal state)
von Emster, Kurt (Abingworth 201507– Managing Partner joined 201501 before venBio + MPM Capital + Franklin Templeton) Partner (venture partner) Abingworth (Group) California (federal state)
von Heijne, Johan (Ratos 201501 CEO of Biolin Scientific) Chief Executive Officer (CEO) Ratos (Group) Sweden_o
von Herrmann, Bruce (Agilent 200708 General Manager + VP Software Div) General Manager (management) Agilent (Group) California (federal state)
von Jako, Ron (GE Healthcare 200807 CMO + Surgical Developm Leader) Chief Medical Officer (CMO) General Electric (Group) South East England (region)
von Mangoldt, Karl (Protembis GmbH 2013– Managing Director + Co-Founder) Managing Director Protembis GmbH Hamburg (federal state)
von Rüden, Thomas (Direvo Biotech –201004 CEO STEPPED DOWN 4/19 before MorphoSys) Chief Executive Officer (CEO) Bayer (Group) Nordrhein-Westfalen (federal state)
von Volkmann, Christian (MagForce 201205– Head of Finance before Jerini CFO + Ernst & Young) Chief Financial Officer (CFO) MagForce (Group) Berlin (federal state)
von Will, Tristana (Biochrom Ltd 201306 Product Marketing Manager) Sales Manager / Marketing Manager Harvard Bioscience (Group) East of England (region)
Vosloo, Mark (Techcomp 201310– CEO of Edinburgh Instruments before Linos Photonics Ltd + Horiba Jobin Yvon Ltd) Chief Executive Officer (CEO) Techcomp (Group) Scotland
Vosloo, Nicola (PerkinElmer 201102 PerkinElmer (UK) Ltd) n. a. PerkinElmer (Group) South East England (region)
Vuillermet, Axelle (NewCap. 201203 Public Relations Manager) Public Relations Manager / Investor Relations Manager NewCap. – Investor Relations & Financial Communications Île-de-France (region)
Waanders, Gary (Bryan Garnier 201709– Managing Director at European Healthcare division before Zeus Capital + Nomura) Managing Director Bryan, Garnier & Co., Ltd. Greater London (region)
Wade-Gery, Laura (Marks & Spencer + Tesco) Board member, non-executive Adaptimmune (Group) South East England (region)
Wadsworth-Hansen, Victoria (Agilent 201506 Director Global Business Public Relations) Public Relations Manager / Investor Relations Manager Agilent (Group) California (federal state)
Wagner, David (GSK 201005 Section Manager DMPK Group) n. a. GlaxoSmithKline (GSK) (Group) United Kingdom (state/region unspecified)
Wake, Ashleigh (Intertek 201509 Biopharmaceutical Services Leder) President/Director/Head Business Group/Unit/Division Intertek (Group) North West England (region)
Wakefield, James (Novacyt 201704 Board Chairman) Board member, non-executive Novacyt (Group) Île-de-France (region)
Walbert, Timothy P. (Horizon Pharma 201003– CEO before IDM Pharma CEO before NeoPharm + Abbott) Chief Executive Officer (CEO) Takeda (Group) California (federal state)
Walder, Adrienne (Alto Marketing 201010 Account Director) Public Relations Manager / Investor Relations Manager Alto Marketing Ltd. South East England (region)
Waldmann, Herbert (MPI für molekulare Physiologie 200503) n. a. Max Planck Society for the Advancement of Science Nordrhein-Westfalen (federal state)
Walker, Adam (Informa 201307 Finance Director) Chief Financial Officer (CFO) Informa Group (Group) Central Switzerland (region)
Walker, Anthony (Alacrita 2009– Founding Partner before Onyvax CEO + co-founder before consultant) Company Founder Alacrita (Group) Greater London (region)
Walker, Jerry (Lab21 –200710– CEO) Chief Executive Officer (CEO) Novacyt (Group) South East England (region)
Walker, Paul (Spectris 201309 Managing Director of Malvern Instruments Ltd) Managing Director Spectris (Group) West Midlands (region)
Walker, Ross (Oxford RF Sensors 200506 CEO) Chief Executive Officer (CEO) Oxford NanoLabs Ltd. South East England (region)
Wallace, Paul (Mission Therapeutics 201503– CBO before Medivir AB Head of Business Development) Chief Business Officer (CBO) Mission Therapeutics Ltd. East of England (region)
Wallace, Paul (QCMD 201310 Managing Director) Managing Director Quality Control for Molecular Diagnostics Ltd. (QCMD) Scotland
Walldén, Erik (Gyros 200903–201310 CEO RESIGNED 10/13 before Affibody CEO + Biacore CEO + Pyrosequencing CEO) Chief Executive Officer (CEO) Gyros (Group) Uppsala (region)
Waller, Ivana (Accovion 201010 COO) Chief Operating Officer (COO) Clinipace (Group) Hessen (federal state)
Waller, John (OracleBio 201111 Director) President/Director/Head Business Group/Unit/Division OracleBio Ltd. Scotland
Wallis, Tim (Ridgeway Biologicals 201701 Managing Director) Managing Director Klocke (Group) South East England (region)
Walls, Matthew (EpiStem 200704 CEO) Chief Executive Officer (CEO) Epistem (Group) North West England (region)
Walmsley, Emma (GSK 201704– CEO before CEO of GSK Consumer Healthcare division joined GSK 2010 from L’Oréal) Chief Executive Officer (CEO) GlaxoSmithKline (GSK) (Group) United Kingdom (state/region unspecified)
Walport, Mark (Wellcome Trust 2010 Director) n. a. Wellcome Trust, The Greater London (region)
Walsh, Andrew (Cambridge Enterprise 200804 Technology Manager) IP Manager University of Cambridge East of England (region)
Walters, Julie (Tudor Reilly 2007– Managing Director + Founder) Managing Director Tudor Reilly Ltd. (Tudor Reilly Health) Greater London (region)
Walther, Hansjörg (Solvias 2003–201402 CEO joined 1999 RETIRED 3/14) Chief Executive Officer (CEO) Solvias (Group) Northwestern Switzerland (region)
Walts, Alan (Advent Life Sciences 201702 Venture Partner) Partner (venture partner) Advent Venture Partners (Advent Ltd.) Greater London (region)
Wambutt, Rolf (AGOWA 200503) n. a. LGC (Group) Berlin (federal state)
Wanchoo, Vishal (GE Healthcare 200509 CEO of GE Healthcare Information Technologies) Chief Executive Officer (CEO) General Electric (Group)
Wandersee, Christian (Vasopharm GmbH 201306 Managing Director) Managing Director Vasopharm GmbH Bayern (federal state)
Wang, Wenyong (Adaptimmune 201604– VP Business Development before Evolution Life Science Partners + Burrill Secutiries) Business Development Manager / Strategy Manager Adaptimmune (Group) South East England (region)
Wang, Yongdong (Cerno Bioscience 200903 President) Chief Executive Officer (CEO) Cerno Bioscience LLC Connecticut (federal state)
Warburton, Elaine (QuantuMDx 200803– CEO + Co-founder before Opaldia CEO) Chief Executive Officer (CEO) QuantuMDx (Group) North East England (region)
Warburton, Mark (Cyprotex 201608 COO + Legal Counsel) Chief Operating Officer (COO) Evotec (Group) North West England (region)
Ward, Barrie (Board Member at several companies in 2012 before CEO of Kudos) Board member, non-executive CellCentric Ltd. East of England (region)
Ward, Malcolm (Proteome Sciences 201009 CTO) Chief Technology/Technical Officer (CTO) Proteome Sciences (Group) South East England (region)
Ward, Sean (Synthace 201708 CTO) Chief Technology/Technical Officer (CTO) Synthace Ltd. Greater London (region)
Ward-Lilley, James (Vectura 201603 CEO) Chief Executive Officer (CEO) Vectura (Group) South West England (region)
Wardle, Kay (Coulter Partners 201712) Human Resources Manager Coulter Partners (The Coulter Partnership Ltd.) Greater London (region)
Warffemius, Pierre (SynCo Bio Partners 201105 CEO) Chief Executive Officer (CEO) SynCo Bio Partners B.V. North Holland (province, NL)
Warmuth, Markus (Eisai 201309 CEO of H3 Biomedicine) Chief Executive Officer (CEO) Eisai (Group) Massachusetts (federal state)
Warne, Mark (IP Group 201411 Healthcare Portfolio Director + Activiomics 201004 Interim CEO) Investment Manager IP Group (Group) Greater London (region)
Warren, Jeremy (NanoSight Ltd 201309 CEO) Chief Executive Officer (CEO) Spectris (Group) South West England (region)
Wass, Ed (Catapult Ventures 201509) Investment Manager Catapult Ventures (Group) East Midlands (region)
Waterfield, Mike (Piramed 200605 Co-founder) Company Founder Roche (Group) South East England (region)
Waterworth, Toby Wilson (Atlantic Healthcare plc 201603 CEO) Chief Executive Officer (CEO) Atlantic Healthcare plc East of England (region)
Watkin, David J. (Univ Oxford 201009 Dept Chemistry Director Chemical Crystallography Lab) Researcher (university / research institute) University of Oxford United Kingdom (state/region unspecified)
Watkins, H. Thomas (HGSI 200512 CEO) Chief Executive Officer (CEO) GlaxoSmithKline (GSK) (Group) Maryland (federal state)
Watson, Dave (Univ Strathclyde 201003 Prof + ScotMet) Professor University of Strathclyde (Glasgow) Scotland
Watson, David (Lhasa Ltd 201302 CEO) Chief Executive Officer (CEO) Lhasa Ltd. Yorkshire and the Humber (region)
Watson, Lorna (Northbank Communications 200608 Senior Account Manager) n. a. Instinctif Partners (Group) Greater London (region)
Watson, Nicola (Schauenburg 201412 at Markes international) n. a. Schauenburg (Group) Wales
Watt, Fiona (Univ Cambridge 201203 Professor of Molecular Genetics) Professor University of Cambridge East of England (region)
Watts, Richard (Qiagen 201004– Director Pharma Business Development before Pharma Regional Marketing Manager) Business Development Manager / Strategy Manager Qiagen (Group) Nordrhein-Westfalen (federal state)
Watts, Ryan (Denali Therapeutics 201608 CEO) Chief Executive Officer (CEO) Denali Therapeutics (Group) California (federal state)
Watts, Sam (Stratophase 201110 Business Development + Commercial Officer + co-founder) Business Development Manager / Strategy Manager Stratophase Ltd. South East England (region)
Watts, Tim (Oxford BioMedica 2012–201709 CFO RETIRED 9/17) Chief Financial Officer (CFO) Oxford BioMedica (Group) South East England (region)
Weaver, Greg (Oryzon Genomics 201504 Non-executive Director before CFO) Board member, non-executive Oryzon Genomics (Group) Madrid (region)
Weaver, Richard (XenoGesis 201109– Managing Director + Founder before AstraZeneca R&D) Managing Director XenoGesis Ltd. East Midlands (region)
Weaver, Tom (Congenica 201309– CEO before MRC + Source BioScience formerly Medical Solutions + Geneservice) Chief Executive Officer (CEO) Congenica (Group) East of England (region)
Webb, Andrew (EKF Diagnostics 201303– CEO of EKF Molecular Diagnostics before Qiagen/DxS + Amersham Pharmacia Biotech) Chief Executive Officer (CEO) EKF Diagnostics (Group) Greater London (region)
next pagenext page 1 2 3 ... 31 32 33  next pagenext page


Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture [MSC] – The Mass Spectrometry Web Portal 600x80px

» top


Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 120x240px Picture [LSE] – The Business Web Portal 120x600px Picture Berlin Partner HealthCapital Bionnale 2018 June Matchmaking 120x240px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px